Omeros OMER
NASDAQ OMER
$18.95 -0.16 (-0.84%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omeros (OMER) Free Cash Flow (2010 - 2026)

Omeros (OMER) posted Free Cash Flow of -$14.5 million for Q1 2026, up 63.59% sequentially from -$39.8 million in Q4 2025, and up 59.57% YoY from -$9.1 million in Q1 2025.

Analysis

Omeros (OMER) Free Cash Flow (2010 - 2026) Analysis & Trends

Omeros has reported Free Cash Flow for 17 years, with the latest figure at -$14.5 million in Q1 2026.

  • Quarterly Free Cash Flow rose 59.57% year-over-year to -$14.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$94.8 million (up 33.72% YoY) and the FY2025 annual result came in at -$116.2 million, up 22.02% from the prior year.
  • Free Cash Flow climbed to -$14.5 million in Q1 2026 per OMER's latest filing, from -$39.8 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $174.5 million in Q1 2023 and troughed at -$46.1 million in Q2 2024.
  • A 5-year average of -$17.2 million and a median of -$29.0 million in 2024 frame the typical range for Free Cash Flow.
  • The sharpest annual moves came in 2023 and 2024: Free Cash Flow soared 1248.81% in 2023, then sank 123.97% in 2024.
  • Over 5 years, Free Cash Flow stood at -$25.4 million in 2022, then tumbled by 37.6% to -$34.9 million in 2023, then gained by 16.99% to -$29.0 million in 2024, then slumped by 37.36% to -$39.8 million in 2025, then surged by 63.59% to -$14.5 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$14.5 million, -$39.8 million, and -$18.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -389.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 477.44 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -95.09 Mn
10 Omeros 1.38 Bn 1.38 Bn 27.73 Mn 4.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.10 Mn
Mar 31, 2026 -14.51 Mn
Dec 31, 2025 -39.79 Mn
Sep 30, 2025 -18.53 Mn
Jun 30, 2025 -21.95 Mn
Mar 31, 2025 -35.88 Mn
Dec 31, 2024 -29.01 Mn
Sep 30, 2024 -32.06 Mn
Jun 30, 2024 -46.07 Mn
Mar 31, 2024 -41.84 Mn
Dec 31, 2023 -34.94 Mn
Sep 30, 2023 -32.68 Mn
Jun 30, 2023 -32.62 Mn
Mar 31, 2023 174.54 Mn
Dec 31, 2022 -25.40 Mn
Sep 30, 2022 -26.44 Mn
Jun 30, 2022 -19.47 Mn
Mar 31, 2022 -15.19 Mn
Dec 31, 2021 -18.29 Mn
Sep 30, 2021 -23.76 Mn